The FDA has issued a notice warning of a potential issue with the CVAC aspiration system marketed by Calyxo. This communication comes as part of an FDA pilot to enhance its medical device recall program. The FDA issued its notice after becoming aware of a potentially high-risk device issue. Calyxo sent affected providers an urgent […]
Calyxo
FDA clears redesigned kidney stone treatment tech from Calyxo
Calyxo announced today that it received FDA clearance for its new, redesigned CVAC system for minimally invasive kidney stone treatment. Pleasanton, California–based Calyxo’s CVAC system uses irrigation and aspiration to remove kidney stones. The design aims to minimize residual stone burden. CVAC’s original design, which used steerable ureteroscopic renal evacuation (SURE) already successfully treated more […]
Calyxo closes $50M funding round to support kidney stone treatment
Calyxo announced that it closed a $50 million Series D financing round to support its CVAC aspiration system for kidney stone removal. Avidity Partners led the round, with existing investors Questa Capital and CRG providing significant participation. Pleasanton, California–based Calyxo’s CVAC system uses irrigation and aspiration to remove kidney stones. The design aims to minimize […]
Calyxo raises $32.7M for kidney stone treatment
Kidney stone removal technology developer Calyxo announced today that it closed a $32.7 million Series C financing round. Pleasanton, California–based Calyxo develops the CVAC Aspiration system designed to use irrigation and aspiration to remove kidney stones with the goal of a surgically stone-free outcome. According to a news release, Questa Capital and CRG led the […]
